At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
In Brief
An observational study for Pediatrics and 3 related conditions. Completed, enrolled 53 participants across 1 site.
Detailed Summary
The purpose of this study is to identify if circulating platelet cyclic adenosine monophosphate (cAMP) levels can be used as a biomarker of milrinone efficacy in children following cardiac surgery or undergoing heart transplant.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPediatrics, Heart Failure, Congenital Heart Disease, Therapeutics
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartAug 2016
Primary CompletionAug 2017
TodayJul 2026
First PostedApr 5, 2016
Enrollment StartAug 1, 2016
Primary CompletionAug 17, 2017
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 10.2 years ago